Wuxi Biortus Biosciences

About:

Wuxi Biortus Biosciences is an innovation-driven contract research organization committed to high-quality R&D services in drug discovery.

Website: https://en.wuxibiortus.com/

Top Investors: Legend Capital, Sherpa Healthcare Partners, Bayland Capital, Kangjun Capital

Description:

Wuxi Biortus Biosciences is an innovation-driven contract research organization (CRO) committed to high-quality R&D services in support of drug discovery. To help our clients achieve their drug discovery goals, we have established five world-class research platforms. These are Recombinant Protein Production, Structural Biology (X-ray Crystallography and Cryo-EM), In Vitro Assays and Screening, Medicinal Chemistry, and Process Development. Through the years, our R&D team has developed a number of practical and innovative techniques of which some have already been granted patent.

Total Funding Amount:

$46.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Jiangyin, Jiangsu, China

Founded Date:

2009-01-01

Contact Email:

info(AT)wuxibiortus.com

Founders:

Number of Employees:

251-500

Last Funding Date:

2021-11-05

IPO Status:

Private

Industries:

© 2025 bioDAO.ai